FIND DOCTORS
-
Name: Dai Bo
Department: UROLOGY
Title:ProfessorEducation & Professional Experience 2015-Chief physician, Department of Urology, Fudan University Shanghai Cancer Center
2010- Deputy chief physician, Department of Urology, Fudan University Shanghai Cancer Center
2009.1 Clinical Observer, Memorial Sloan-Kettering Cancer Center, New York
2006-2010 Attending Urologist, Department of Urology, Fudan University Shanghai Cancer Center
2005-2008 Doctor Degree in Oncology at Fudan University
2003-2006 Resident, Department of Urology, Fudan University Shanghai Cancer Center
2000-2003 Master Degree in Oncology at Fudan University
1995-2000 Bachelor Degree in Medicine at Fudan University
Specialty Prostate cancer, bladder cancer, kidney cancer, testis cancer, penile cancer, adrenal tumor Research Study the nature, cause, development and clinical management of urologic cancers, including prostate cancer, bladder cancer, kidney cancer, testicular cancer, penile cancer, etc.
Grants:
1. National Natural Science Foundation of China [No. 30801149; 2009.1-2011.12]
2. International Cooperation and Exchange of Science and Technology Commission of Shanghai Municipality [No. 12410709300; 2012.10-2014.10]
3. Guide Project of Science and Technology Commission of Shanghai Municipality [No. 124119a7300; 2013.1-2014.12]
4. Outstanding young talent training plan of Shanghai Municipal Commission of Health and Family Planning (No. XYQ2013102; 2013.12-2016.12)Publication 1.Dai B, Kong YY, Chang K, Qu YY, Ye DW, Zhang SL, Zhang HL. Primary invasive carcinoma associated with penoscrotal extramammary Paget's disease: A clinicopathologic analysis of 56 cases. BJU Int. 2015 Jan; 115(1): 153-60.
2.Qu Y, Dai B (corresponding author), Ye D, Kong Y, Chang K, Jia Z, Yang X, Zhang H, Zhu Y, Shi G.. Constitutively Active AR-V7 Plays an Essential Role in the Development and Progression of Castration-Resistant Prostate Cancer. Sci Rep. 2015 Jan 7;5:7654.
3.Dai B, Kong YY, Cai X, Shen XX, Kong JC. Spiradenocarcinoma, Cylindrocarcinoma and Spiradenocylindrocarcinoma: A Clinicopathologic Study of 9 cases. Histopathology. 2014 Nov; 65(5): 658-66.
4.Dai B, Qu YY, Kong YY, Ye DW, Yao XD, Zhang SL, Zhang HL, Yang WY. Kinetics of testosterone recovery in clinically localized prostate cancer patients treated with radical prostatectomy and subsequent short-term adjuvant androgen deprivation therapy. Asian J Androl. 2013 Jul; 15(4): 466-70.
5.Chang K, Dai B [Co-first Author], Kong YY, Qu YY, Gan HL, Gu WJ, Ye DW, Zhang HL, Zhu Y, Shi GH. Genitourinary small-cell carcinoma: 11-year treatment experience. Asian J Androl. 2014 Sep-Oct; 16(5): 705-9..
6.Qu YY, Dai B [Co-first Author], Kong YY, Chang K, Ye DW, Yao XD, Zhang SL, Zhang HL, Yang WY. Influence of obesity on localized prostate cancer patients treated with radical prostatectomy. Asian J Androl. 2013 Nov 15(6):747-52.
7.Chang K, Dai B [Co-first Author], Kong Y, Qu Y, Wu J, Ye D, Yao X, Zhang S, Zhang H, Zhu Y, Yao W. Basal cell carcinoma of the prostate: clinicopathologic analysis of three cases and a review of the literature. World J Surg Oncol. 2013 Aug 13;11(1):193.
8.Qu YY, Dai B [Co-first Author], Kong YY, Ye DW, Yao XD, Zhang SL, Zhang HL, Ma CG, Yang WY. Prognostic factors in Chinese patients with metastatic castration-resistant prostate cancer treated with docetaxel-based chemotherapy. Asian J Androl. 2013 Jan;15(1):110-5.
9.Dai B, Qu Y, Kong Y, Ye D, Yao X, Zhang S, Wang C, Zhang H, Yang W. Low pretreatment serum total testosterone is associated with a high incidence of Gleason score 8-10 disease in prostatectomy specimens: data from ethnic Chinese patients with localized prostate cancer. BJU Int. 2012 Dec; 110 (11 Pt B): E667-72.
10.Dai B, Kong YY, Ye DW, Xu XW, Yao XD, Zhang SL. Basal Cell Carcinoma of the Scrotum: Clinicopathologic Analysis of 10 Cases. Dermatol Surg. 2012 May; 38(5): 783-90.
11.Kong YY, Dai B [Co-first Author], Kong JC, Zhou XY, Lu HF, Shen L, Du X, Shi DR. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathologic, immunophenotypic, and molecular study of 22 Asian cases according to WHO-EORTC classification. Am J Surg Pathol. 2008 Oct;32(10):1495-502. (SCI)
12.Dai B, Kong YY, Ye DW, Ma CG, Zhou X, Yao XD. Activation of the mammalian target of rapamycin signalling pathway in prostate cancer and its association with patient clinicopathological characteristics. BJU Int. 2009, 104(7): 1009-1016.
13.Dai B, Kong YY, Ye DW, Ma CG, Zhou XY, Yao XD. Human epidermal growth factor receptor type 2 protein expression in Chinese metastatic prostate cancer patients correlates with cancer specific survival and increases after exposure to hormonal therapy. Asian J Androl. 2008 (5): 01-9.
14.Dai B, Ye DW, Kong YY, Shen YJ, Wang BH. Individualized prostate biopsy strategy for Chinese patients with different prostate-specific antigen levels. Asian J Androl, 2008, 10(2): 325-31.
Dai B, Ye DW, Kong YY, Yao XD, Zhang HL, Shen YJ. Predicting regional lymph node metastasis in Chinese patients with penile squamous cell carcinoma: the role of histopathological classification, tumor stage and depth of invasion. J Urol, 2006, 176(4 Pt 1): 1431-5.
Awards 2013 Outstanding master tutor of Fudan University Shanghai Cancer Center
2013 Outstanding young talent training plan of Shanghai Municipal Commission of Health and Family Planning
2013 Scientific and technological progress award of the Ministry of Education, Second
Prize (third rank)
2012 Science and Technology Award of Shanghai Medical Association, First Prize (third rank)
2012 Excellent young and middle-aged physician paper competiton of Shanghai Medical Association, Second Prize
2011 Science and Technology Progress Award of Education Ministry, First Prize (third rank)
2010 Shanghai Science and Technology Progress Award, First Prize (third rank)
2010 Excellent attending physician of Fudan University Shanghai Cancer Center
2010 Chinese Medical Science and Technology Progress Award, Second Prize (third rank)
2010 Shanghai Medical Science and Technology Award, Second Prize (third rank)
2010 Science and Technology Award of Chinese Anti-Cancer Association, Second Prize (third rank)
2009 Top ten young doctors of Fudan University
2007 Young physician excellent paper competiton of Urology Academic Conference in East China, Second Prize
2005 Young physician excellent paper competiton of Urology and Andrology Academic Conference in East China, Excellence Award
Out-patient Schedule Monday afternoon, Wednesday afternoon
